866-997-4948(US-Canada Toll Free)

Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2019

Published By :

GlobalData

Published Date : May 2019

Category :

Medical Equipments

No. of Pages : 82 Pages

Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2019" provides an overview of Positron Emission Tomography (PET) Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Positron Emission Tomography (PET) Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Positron Emission Tomography (PET) Systems under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Positron Emission Tomography (PET) Systems and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry.

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Positron Emission Tomography (PET) Systems under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date.
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Positron Emission Tomography (PET) Systems Overview
3 Products under Development
3.1 Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
3.2 Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
3.3 Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
3.4 Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date
4 Positron Emission Tomography (PET) Systems - Pipeline Products under Development by Companies
4.1 Positron Emission Tomography (PET) Systems Companies - Pipeline Products by Stage of Development
4.2 Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
5 Positron Emission Tomography (PET) Systems Companies and Product Overview
5.1 Brain Biosciences Inc Company Overview
5.2 GE Healthcare LLC Company Overview
5.3 General De Equipment for Medical Imaging SA Company Overview
5.4 Jagiellonian University Company Overview
5.5 Lightpoint Medical Ltd Company Overview
5.6 Neurovation Labs Inc Company Overview
5.7 Nuclear, Plasma, and Radiological Engineering Company Overview
5.8 Philips Healthcare Company Overview
5.9 Ray Vision Intl Corp. Company Overview
5.10 Stanford University Company Overview
5.11 SynchroPET Company Overview
5.12 University of British Columbia Company Overview
5.13 University of Washington Company Overview
5.14 West Virginia University Company Overview
6 Positron Emission Tomography (PET) Systems- Recent Developments
6.1 Mar 25, 2019: Inflazome receives funding from The Michael J. Fox Foundation for Parkinsons Research
6.2 Mar 18, 2019: European Association of Urology issues updated guidelines for prostate cancer imaging
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

1.1 List of Tables
Table 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
Table 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
Table 3: Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
Table 4: Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date
Table 5: Positron Emission Tomography (PET) Systems Companies - Pipeline Products by Stage of Development
Table 6: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
Table 7: Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 8: CerePET - Product Status
Table 9: CerePET - Product Description
Table 10: FREEMotion - Product Status
Table 11: FREEMotion - Product Description
Table 12: GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Q.Clear - Product Status
Table 14: Q.Clear - Product Description
Table 15: General De Equipment for Medical Imaging SA Pipeline Products & Ongoing Clinical Trials Overview
Table 16: CareMiBrain - Product Status
Table 17: CareMiBrain - Product Description
Table 18: Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Positron Emission Tomography System - Product Status
Table 20: Positron Emission Tomography System - Product Description
Table 21: Lightpoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 22: HARLI - Product Status
Table 23: HARLI - Product Description
Table 24: Neurovation Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 25: NVL1 Diagnostic Tracer - Product Status
Table 26: NVL1 Diagnostic Tracer - Product Description
Table 27: Nuclear, Plasma, and Radiological Engineering Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Head And Neck PET System - Product Status
Table 29: Head And Neck PET System - Product Description
Table 30: Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Additional PET Scan - Product Status
Table 32: Additional PET Scan - Product Description
Table 33: Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Helmet - PET System - Product Status
Table 35: Helmet - PET System - Product Description
Table 36: Stanford University Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Breast-Dedicated PET System - Product Status
Table 38: Breast-Dedicated PET System - Product Description
Table 39: Dual Panel PET Scanner - Product Status
Table 40: Dual Panel PET Scanner - Product Description
Table 41: Dual-isotope Positron Emitting Tomography System - Product Status
Table 42: Dual-isotope Positron Emitting Tomography System - Product Description
Table 43: MR Compatible PET System - Product Status
Table 44: MR Compatible PET System - Product Description
Table 45: Next Generation TOF-PET System - Product Status
Table 46: Next Generation TOF-PET System - Product Description
Table 47: PET Sensitivity Enhancing Device - Product Status
Table 48: PET Sensitivity Enhancing Device - Product Description
Table 49: PET System - Product Status
Table 50: PET System - Product Description
Table 51: SynchroPET Pipeline Products & Ongoing Clinical Trials Overview
Table 52: Arterial PET Scanner - Product Status
Table 53: Arterial PET Scanner - Product Description
Table 54: Breast PET-MRI - Product Status
Table 55: Breast PET-MRI - Product Description
Table 56: University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
Table 57: PET Imaging Tool - Product Status
Table 58: PET Imaging Tool - Product Description
Table 59: University of Washington Pipeline Products & Ongoing Clinical Trials Overview
Table 60: DS-PS3 Positron Emission Tomography Detector - Product Status
Table 61: DS-PS3 Positron Emission Tomography Detector - Product Description
Table 62: High Resolution PET Detector - Product Status
Table 63: High Resolution PET Detector - Product Description
Table 64: PET-Mammogram-Biopsy System - Product Status
Table 65: PET-Mammogram-Biopsy System - Product Description
Table 66: West Virginia University Pipeline Products & Ongoing Clinical Trials Overview
Table 67: Positron Emission Tomography (PET) Imager - Product Status
Table 68: Positron Emission Tomography (PET) Imager - Product Description
Table 69: Glossary

1.2 List of Figures
Figure 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
Figure 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
Figure 3: Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
Figure 4: Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *